Israeli firm gets U.S. nod for advanced trials for non-opiate painkiller

Israeli pharmaceuticals company PainReform has received approval from the U.S. Food and Drug Administration (FDA) to begin late-stage clinical studies for a pain relief drug that is a departure from opiate-based narcotics, it said on Tuesday.

Hormone therapy poses stroke risk for transgender women

(Reuters Health) - Hormones given to people to align their sex with their gender pose a significant risk of serious blood clots and stroke among transgender women, one of the largest studies of transgender patients has concluded.

Trump slams Pfizer after July 1 drug price hikes

U.S. President Donald Trump on Monday took aim at Pfizer Inc and other U.S. drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response.

Fewer older black patients survive long-term after cardiac arrest in the hospital

(Reuters Health) - After a cardiac arrest in the hospital, older black patients don't survive as long as older white patients, new data show.

Danone investigates Aptamil baby milk complaints

French food group Danone is investigating reports that its new Aptamil baby milk formula has made some infants unwell in Britain.

Team mix affects operating room social behavior

(Reuters Health) - Social behavior in the operating room is significantly affected by the mix of professional roles and the surgeon's gender, according to researchers who observed 200 surgical procedures.

CTI Biopharma's cancer drug fails late-stage trial, shares tumble

CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage trial, sending its shares down 17 percent.

Insurers warn of rising premiums after Trump axes Obamacare payments again

Health insurers warned that a move by the Trump administration on Saturday to temporarily suspend a program that was set to pay out $10.4 billion to insurers for covering high-risk individuals last year could drive up premium costs and create marketplace uncertainty.

Trump administration halts billions in insurance payments under Obamacare

The Trump administration on Saturday halted billions of dollars in payments to health insurers under the Obamacare healthcare law, saying that a recent federal court ruling prevents the money from being disbursed.

Cancer diagnosis tied to increased risk of diabetes

(Reuters Health) - People who get diagnosed with cancer may be more likely to develop diabetes, a Korean study suggests.

Biogen, Eisai's Alzheimer's drug succeeds in mid-stage trial, shares soar

Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer's drug showed positive results for patients who received the highest dose.

Related Videos

Researchers perfect fingerprint technique to protect pangolins

Researchers in the UK perfect a method of recovering the fingerprints of pangolin poachers from the animal's scales, as Stuart McDill reports.

Scientists hope test-tube embryos can save near-extinct white rhino

Scientists have created hybrid embros from the sperm of near-extinct northern white rhinoceroses in the laboratory, hoping they can ultimately help save the species. Scarlett Cvitanovich reports.
You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here